<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Data Cannot Lie</title>
    <link rel="stylesheet" href="styles.css">
 
</head>
<body>
    <header>
        <div class="header-content">
            <h1>Data Cannot Lie</h1>
            <p>A Data Analysis Endeavour</p>
            <blockquote class="famous-quote">
                <p>"In God we trust. All others must bring data."</p>
                — W. Edwards Deming
            </blockquote>
        </div>
    </header>
    <nav class="sidebar">
        <ul>
            <li><a href="#post1">Healthcare expenditure and CVD incidence</a></li>
            <li><a href="#author-bio">About the Author</a></li>
        </ul>
    </nav>   

    <main>
        <article class="blog-post">
            <h2>The Impact of Federal Investment in Public Health on Cardiovascular Disease Incidence:
                 A Comparative Analysis (2000-2020)</h2>
            <p class="date">Published on [Date]</p>

            <p>I have always believed that government spending on education and healthcare should be seen 
                not as expenses, but as investments. Investing in healthcare, for example, can improve 
                the overall health of the population, enhance quality of life, and strengthen the national 
                workforce. This, in turn, boosts productivity and reduces early retirements and work 
                absences due to health issues, lessening the strain on social security. Let's consider the 
                case of cardiovascular diseases. This essay examines the relationship between federal 
                investment in public health and the incidence of cardiovascular diseases across six 
                countries — the United States, Brazil, Japan, Australia, Cuba, and Finland — focusing on 
                their healthcare investments from 2000 to 2020.
            </p>

               
            <p>Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide, prompting nations 
                to invest heavily in public health initiatives aimed at prevention and treatment (
                Benjamin et al., 2019). Figure 1 illustrates the evolution of CVD rates in five 
                countries between 2000 and 2020. Despite a reduction in CVD mortality across all the 
                countries analyzed, it remains higher in Brazil and Cuba and lower in Japan and Australia.
            </p>    

            <div id="plotly-graph">
                <!-- Figure line_cvd_2000_2020.html here -->
                <iframe src="https://github.com/datacannotlie/data_cannot_lie_blog/line_cvd_2000_2020.html" width="100%" height="800px" frameborder="0"></iframe>                 
            </div>

            <p>Figure 1: Cardiovascular disease (CVD) mortality rate per 100,000 people from 2000 to 2020 for Australia, 
                Cuba, Japan, Brazil, Finland, and the United States. The interactive plot allows you to hover over data 
                points for specific values and compare trends across countries over time.
            </p>

            <p>When we consider the healthcare expenditure (as percentage of GDP), we observe that along the time, 
                the investiment is increasing for all countries analyzed but USA has the highest healthcare expenditure, 
                while Finland and Brazil present the lowest values.
            </p>
        
            <p>A comparative analysis, showed in figure 3, reveals diverse outcomes among the six countries, 
                highlighting the complex relationship between healthcare spending and 
                CVD incidence. Despite high healthcare expenditures, the United States 
                has shown only a modest decrease in CVD mortality rates (Frieden & Berwick, 2011), 
                suggesting that high spending alone does not guarantee optimal outcomes. 
                In contrast, Brazil's focus on preventive care and health education has led 
                to a notable reduction in CVD mortality rates, emphasizing the importance of 
                efficient resource allocation (Ribeiro et al., 2016). This demonstrates that 
                middle-income nations can achieve significant improvements through targeted 
                public health strategies. Japan's consistently low CVD incidence, attributed 
                to a combination of factors including a healthy diet, active lifestyle, and 
                emphasis on preventive care (Iso, 2011), further underscores the importance 
                of cultural factors and lifestyle in CVD prevention.
            </p>       
        
            <p>The experiences of Australia, Cuba, and Finland provide additional insights 
                into effective strategies for reducing CVD incidence. Australia has demonstrated 
                a strong correlation between increased healthcare spending and reduced CVD mortality, 
                highlighting the importance of well-targeted public health investments (Australian Institute 
                of Health and Welfare, 2021). Cuba's remarkable success in reducing CVD mortality rates, 
                despite limited economic resources, shows that efficient allocation of resources can be 
                crucial (Cooper et al., 2006). This underscores the potential for significant health 
                improvements even with constrained budgets. Finland's comprehensive approach, including 
                the North Karelia Project, serves as a model for other countries. It emphasizes the 
                importance of long-term commitment to public health initiatives and addressing social 
                determinants of health, such as education, housing, and employment (Puska, 2002).
            </p>

            
            <div id="plotly-graph">
                <!-- Figure line_hc_2000_2020.html here -->
                <iframe src="line_hc_2000_2020.html" width="100%" height="800px" frameborder="0"></iframe>
            </div>
            
            <p>Figure 2: Investiment in healthcare from 2000 to 2020 for Australia, 
                Cuba, Japan, Brazil, Finland, and the United States. The interactive plot allows you to 
                hover over data points for specific values and compare trends across countries over time.
            </p>
    
            <p>Across all studied countries, the role of technology in CVD prevention and treatment has 
                become increasingly important. Investments in digital health infrastructure, telemedicine, 
                and mobile health applications have improved access to healthcare services, particularly in 
                rural and underserved areas (World Health Organization, 2019). Additionally, research in 
                genomics and precision medicine has led to targeted interventions and personalized treatment 
                plans, enhancing the effectiveness of CVD prevention and treatment (National Institutes of 
                Health, 2020). Community-based initiatives, such as public health campaigns and health 
                education programs, have also been effective in promoting healthy lifestyles and reducing 
                CVD risk factors (Centers for Disease Control and Prevention, 2020).
            </p>

            <div id="plotly-graph">
                <!-- Figure cvd_hc.html here -->
                <iframe src="cvd_hc.html" width="100%" height="600px" frameborder="0"></iframe>
            </div>

            <p>Figure 3: Cardiovascular disease (CVD) mortality rate per 100,000 people from 2000 to 2020 as 
                function of the healthcare expenditure for Australia, Cuba, Japan, Brazil, Finland, and the United States, 
                for the period between 2000 and 2020.
            </p>
    
            <p>The evidence suggests that increased investment in public health is generally associated with 
                better outcomes, but the effectiveness of this spending varies significantly based on how 
                it is allocated and the specific context of each country. Key factors that enhance the impact 
                of healthcare expenditures include a focus on preventive care, public health education, 
                policies promoting healthy lifestyles, equitable access to healthcare services, integration 
                of CVD prevention into primary care, and investment in research and innovation.</p>

            <div id="plotly-graph">
                <!-- Figure cvd_hc.html here -->
                <iframe src="hc_projection.html" width="100%" height="650px" frameborder="0"></iframe>
            </div>

            <p>Figure 4: Projeted healthcare expenditure needed to minimize CVD deaths
                    in Australia, Cuba, Japan, Brazil, Finland, and the United States.
            </p>

            <p>Figure 4 presents a theoretical value for healthcare investments needed to minimize 
                CVD incidence in the countries considered here. This value is derived from the 
                projection of the linear regression between CVD incidence and healthcare expenditure. 
                While this is a theoretical value and CVD is complex, it provides a reasonable estimate. 
                As observed in Figure 3, CVD mortality rates in Finland, Australia, and Brazil are 
                more sensitive to healthcare expenditure. Therefore, Figure 4 shows that these three 
                nations could achieve minimized levels of CVD mortality with relatively lower healthcare 
                investments. This would represent a little more than a 50% increase in healthcare investment 
                for Brazil and even less for Finland and Australia. However, for Cuba, minimizing the CVD 
                death rate would require an investment of 45% of GDP, which may be impractical while the 
                economic blockade persists.
            </p>


    
            <h3>Conclusion</h3>
            <p>In conclusion, the comparative analysis reveals that while increased 
                healthcare expenditure is associated with reduced CVD incidence, 
                the relationship is complex and influenced by multiple factors. To 
                maximize the impact of federal investments in public health on CVD 
                incidence, policymakers should focus on evidence-based interventions, 
                preventive care, and addressing social determinants of health. The 
                experiences of these nations underscore the importance of sustained, 
                strategic investment in public health to combat cardiovascular diseases 
                effectively. As global health challenges continue to evolve, countries 
                must adapt their strategies, learn from successful models, and prioritize 
                efficient resource allocation to effectively reduce the burden of 
                cardiovascular diseases and improve overall public health outcomes.
            </p>
    
            <h3>References:</h3>
            <p>
            <ul>
            <li>Australian Institute of Health and Welfare. (2021). Heart, stroke and vascular disease: Australian facts. Canberra: AIHW.</li>
            <li>Benjamin, E. J., et al. (2019). Heart disease and stroke statistics—2019 update: A report from the American Heart Association. Circulation, 139(10), e56-e528.</li>
            <li>Centers for Disease Control and Prevention. (2020). Community Health Worker Training Program. Retrieved from https://archive.cdc.gov/www_cdc_gov/dhdsp/programs/spha/chw_training/index.htm</li>
            <li>Cooper, R. S., Kennelly, J. F., & Orduñez-Garcia, P. (2006). Health in Cuba. International Journal of Epidemiology, 35(4), 817-824.</li>
            <li>Frieden, T. R., & Berwick, D. M. (2011). The "Million Hearts" initiative—preventing heart attacks and strokes. New England Journal of Medicine, 365(13), e27.</li>
            <li>Iso, H. (2011). Lifestyle and cardiovascular disease in Japan. Journal of Atherosclerosis and Thrombosis, 18(2), 83-88.</li>
            <li>National Institutes of Health. (2020). Precision Medicine Initiative. Retrieved from https://www.nih.gov/about-nih/what-we-do/nih-turning-discovery-into-health/promise-precision-medicine</li>
            <li>Puska, P. (2002). Successful prevention of non-communicable diseases: 25 year experiences with North Karelia Project in Finland. Public Health Medicine, 4(1), 5-7.</li>
            <li>Ribeiro, A. L. P., Duncan, B. B., Brant, L. C., Lotufo, P. A., Mill, J. G., & Barreto, S. M. (2016). Cardiovascular health in Brazil: Trends and perspectives. Circulation, 133(4), 422-433.</li>
            <li>World Health Organization. (2019). Digital Health. https://www.who.int/health-topics/digital-health#tab=tab_1 </p>
            </ul>
            <h3>Code and Dataset</h3>
            <p> Health care expenditure dataset from <a href="https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS" target="_blank">World Bank </a></p>
            <p>CVD mortality rate dataset from <a href="https://platform.who.int/mortality/themes/theme-details/topics/topic-details/MDB/cardiovascular-diseases" target="_blank">World Health Organization </a></p></p>
            <p>The code used for this analysis can be found on my <a href="https://github.com/datacannotlie/CVD">GitHub repository</a></p>
           
        </article> 
    </main>

    <section class="author-bio" id="author-bio">
        <img src="eu.png" alt="Author's photo" class="author-photo">
        <div class="bio-content">
            <h2>About the Author</h2>
            <p>I am a Bachelor of Veterinary Medicine from the Federal Rural University of Rio de Janeiro (UFRRJ, 2000, RJ, Brazil) 
                and a Bachelor of Mathematics from Estácio de Sá University (UNESA, 2024, RJ, Brazil). I earned a Master's degree in Physiology 
                from the University of São Paulo (USP, 2002, SP, Brazil) and a Ph.D. in Physiology from the same institution (2006).
                In pursuit of advanced research, I completed a postdoctoral fellowship in the electrophysiology of bulbar neurons 
                at Oregon Health and Science University (OHSU, 2008, OR, USA), followed by a postdoctoral fellowship in mathematical modeling 
                of the cardiovascular system at the National Laboratory for Scientific Computing (LNCC, 2014, RJ, Brazil).           
                Passionate about mathematics and physiology, my research is focused in trying to understanding the neural mechanisms that control the 
                cardiovascular system. You can check out my CV at <a href="http://lattes.cnpq.br/6449468825793021" target="_blank">My CV.</a></p> 
                Also, you can contact me at datacannotlie@gmail.com</p>
        </div>
    </section>

    <footer>
        <p>&copy; 2024 Luciano Gonçalves Fernandes. All rights reserved.</p>
    </footer>
</div>

<!-- Cookie Consent Banner -->
<div id="cookie-consent" class="cookie-consent">
    <p>This website uses cookies to ensure you get the best experience on our website. <a href="#" class="cookie-policy-link">Learn more</a></p>
    <button id="accept-cookies" class="cookie-btn">Accept</button>
    <button id="reject-cookies" class="cookie-btn">Reject</button>
</div>

<script src="script.js"></script>
</body>
</html>
